SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-19-004500
Filing Date
2019-07-10
Accepted
2019-07-10 16:00:43
Documents
3
Period of Report
2019-08-22
Effectiveness Date
2019-07-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_071019.htm DEF 14A 891004
2 GRAPHIC logo.jpg GRAPHIC 7826
3 GRAPHIC sig_holliman.jpg GRAPHIC 4468
  Complete submission text file 0001171843-19-004500.txt   909370
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21214 | Film No.: 19949351
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences